Annora Pharma Private Limited recalls Lacosamide Tablets
- Recalling company
- Annora Pharma Private Limited
- Product
- Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, By: Annora Pharma Pvt., Ltd, Sangareddy -502313, Telangana, India, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, NDC 31722-813-60.
- Reason
- Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Jun 4, 2026
- Reported
- Jul 1, 2026
- Distribution
- Nationwide in the USA
- Status
- Ongoing
- Quantity
- 31,392 60-count bottles
- Lot / codes
- Lot: A253999, A254000, Expires: 09/30/2027.
- Company location
- Hyderabad, N/A
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0626-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0626-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.